Alzheimer’s disease stands as the prevailing form of dementia. It manifests as a gradual ailment, initially marked by slight cognitive impairment and potentially progressing to an inability to engage in meaningful conversations and appropriately react to one’s surroundings. This condition primarily affects regions of the brain responsible for cognition, memory, and linguistic skills.
Here are five notable studies that have shown promising results:
- A study published in the Journal of Alzheimer’s Disease (2014) found that CBD had a positive impact on reducing the production of beta-amyloid proteins, which are a hallmark characteristic of Alzheimer’s disease. The researchers suggested that CBD may have potential therapeutic implications for the treatment of Alzheimer’s disease.
- In a preclinical study published in the Journal of Neuroscience (2017), researchers investigated the effects of CBD on mice with Alzheimer’s disease-like symptoms. They found that CBD improved cognition and reduced the progression of cognitive decline in the mice. The study suggested that CBD may have potential as a treatment option for Alzheimer’s disease.
- Another preclinical study published in the journal Aging and Mechanisms of Disease (2017) examined the effects of CBD on mice with induced Alzheimer’s disease. The researchers found that CBD improved social recognition memory, indicating a potential cognitive-enhancing effect. Additionally, CBD was found to reduce the expression of pro-inflammatory cytokines, suggesting an anti-inflammatory effect that could be beneficial in Alzheimer’s disease.
- A review article published in the journal Frontiers in Pharmacology (2020) discussed the potential therapeutic effects of CBD on Alzheimer’s disease. The authors highlighted the neuroprotective, anti-inflammatory, and antioxidant properties of CBD, which could potentially benefit individuals with Alzheimer’s disease. The review suggested that CBD may help alleviate some of the cognitive and behavioral symptoms associated with the condition.
- A recent study published in the Journal of Alzheimer’s Disease (2021) examined the effects of a combination of CBD and Δ9-tetrahydrocannabinol (THC) on patients with Alzheimer’s disease. The study found that the combination treatment was well-tolerated and resulted in significant improvements in various measures, including reduction in agitation and improvement in quality of life.